abstract |
The disclosures herein relate to novel compounds of formula n n n n n n n n n n wherein Ar 1 and R 1 are as defined herein, and their use in treating, preventing, ameliorating, controlling or reducing cerebrovascular or vascular disorders associated with CGRP receptor function. |